Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-14
Closed -$8.19K – 946
2023
Q4
$8.19K Buy
+14
New +$7.83K ﹤0.01% 221
2023
Q2
– Sell
-44
Closed -$23.7K – 896
2023
Q1
$23.7K Hold
44
– – ﹤0.01% 401
2022
Q4
$22.5K Hold
44
– – ﹤0.01% 401
2022
Q3
$19K Hold
44
– – ﹤0.01% 470
2022
Q2
$21K Buy
+44
New +$21.5K ﹤0.01% 405

Other funds holding CHE

Crewe Advisors's CHE Position: Q1 2024 in Review

Crewe Advisors sold out of Chemed (CHE) in Q1 2024, closing a stake of 14 shares — an estimated $8.19K sold.

Crewe Advisors first reported a position in CHE in Q2 2022 and held it in 5 quarters. The position peaked at $23.7K in Q1 2023. 511 funds tracked by Wall St. Rank hold CHE as of Q1 2024.

  • Crewe Advisors reported no remaining Chemed position as of Q1 2024 after selling out during the quarter.
  • Crewe Advisors sold 14 Chemed shares in Q1 2024, an estimated $8.19K.
  • Crewe Advisors first reported a position in Chemed in Q2 2022 and held it in 5 quarters.
  • Crewe Advisors's Chemed position peaked at $23.7K in Q1 2023.
  • 511 funds tracked by Wall St. Rank held Chemed as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.